The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Open accessAbstract
One of the main goals of nanomedicine is to develop a nanocarrier that can selectively deliver anticancer drugs to the targeted tumors. Extensive efforts have resulted in several tumor-targeted nanocarriers, some of which are approved for clinical use. Most nanocarriers achieve tumor-selective accumulation through the enhanced permeability and retention effect. Targeting molecules such as antibodies, peptides, ligands, or nucleic acids attached to the nanocarriers further enhance their recognition and internalization by the target tissues. While both the stealth and targeting features are important for effective and selective drug delivery to the tumors, achieving both features simultaneously is often found to be difficult. Some of the recent targeting strategies have the potential to overcome this challenge. These strategies utilize the unique extracellular environment of tumors to change the long-circulating nanocarriers to release the drug or interact with cells in a tumor-specific manner. This review discusses the new targeting strategies with recent examples, which utilize the environmental stimuli to activate the nanocarriers. Traditional strategies for tumor-targeted nanocarriers are briefly discussed with an emphasis on their achievements and challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
Weissleder, R., Tung, C.-H., Mahmood, U., & Bogdanov, A. (1999) · Nature Biotechnology · doi:10.1038/7933 · Cited by 1,591
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
(1996) · PubMed · Cited by 1,141
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
Polymer Therapeutics: Concepts and Applications
Haag, R., & Kratz, F. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502113 · Cited by 1,115
Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
Zhang, L., Chan, J. M., Gu, F. X., Rhee, J.-W., Wang, A. Z., Radovic-Moreno, A. F., Alexis, F., Langer, R., & Farokhzad, O. C. (2008) · ACS Nano · doi:10.1021/nn800275r · Cited by 1,038
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
Caliceti, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00108-x · Cited by 947
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Recent progress in tumor pH targeting nanotechnology
Lee, E. S., Gao, Z., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.003 · Cited by 866
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Targeted pharmaceutical nanocarriers for cancer therapy and imaging
Torchilin, V. P. (2007) · The AAPS Journal · doi:10.1208/aapsj0902015 · Cited by 762
Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00015-7 · Cited by 756
Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0498166 · Cited by 742
Mishra, S., Webster, P., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 730
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 715
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · PubMed · Cited by 652
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 645
Folate receptor targeted biodegradable polymeric doxorubicin micelles
Yoo, H. S., & Park, T. G. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.02.003 · Cited by 620
Super pH-Sensitive Multifunctional Polymeric Micelle
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Nano Letters · doi:10.1021/nl0479987 · Cited by 611
Greish, K. (2007) · Journal of Drug Targeting · doi:10.1080/10611860701539584 · Cited by 600
Sheddable Coatings for Long-Circulating Nanoparticles
Romberg, B., Hennink, W. E., & Storm, G. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9348-7 · Cited by 555
“SMART” Drug Delivery Systems: Double-Targeted pH-Responsive Pharmaceutical Nanocarriers
Sawant, R. M., Hurley, J. P., Salmaso, S., Kale, A., Tolcheva, E., Levchenko, T. S., & Torchilin, V. P. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060080h · Cited by 540
Gabizon, A. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.01.011 · Cited by 464
Min, K. H., Park, K., Kim, Y.-S., Bae, S. M., Lee, S., Jo, H. G., Park, R.-W., Kim, I.-S., Jeong, S. Y., Kim, K., et al. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.013 · Cited by 460
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
Gabizon, A. A. (2001) · Cancer Investigation · doi:10.1081/cnv-100103136 · Cited by 458
Lee, E. S., Oh, K. T., Kim, D., Youn, Y. S., & Bae, Y. H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.006 · Cited by 446
Breaking up the correlation between efficacy and toxicity for nonviral gene delivery
Breunig, M., Lungwitz, U., Liebl, R., & Goepferich, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703882104 · Cited by 443
Polymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.012 · Cited by 436
Drug Delivery by Soft Matter: Matrix and Vesicular Carriers
Soussan, E., Cassel, S., Blanzat, M., & Rico‐Lattes, I. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802453 · Cited by 433
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins.
Rennke, H. G., Cotran, R. S., & Venkatachalam, M. A. (1975) · The Journal of cell biology · doi:10.1083/jcb.67.3.638 · Cited by 410
Multi-functional nanocarriers to overcome tumor drug resistance
Jabr-Milane, L. S., van Vlerken, L. E., Yadav, S., & Amiji, M. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.04.003 · Cited by 407
Lee, E. S., Gao, Z., Kim, D., Park, K., Kwon, I. C., & Bae, Y. H. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.04.024 · Cited by 400
Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 398
Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., & Park, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1093 · Cited by 382
Sethuraman, V. A., & Bae, Y. H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.008 · Cited by 336
Kakizawa, Y., Harada, A., & Kataoka, K. (1999) · Journal of the American Chemical Society · doi:10.1021/ja993057y · Cited by 331
Chen, H., Kim, S., He, W., Wang, H., Low, P. S., Park, K., & Cheng, J.-X. (2008) · Langmuir · doi:10.1021/la703570m · Cited by 311
Ko, J., Park, K., Kim, Y.-S., Kim, M. S., Han, J. K., Kim, K., Park, R.-W., Kim, I.-S., Song, H. K., Lee, D. S., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.012 · Cited by 302
In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizón, A., Horowitz, A. T., Goren, D., Tzemach, D., Shmeeda, H., & Zalipsky, S. (2003) · PubMed · Cited by 295
Lukyanov, A. N., Elbayoumi, T. A., Chakilam, A. R., & Torchilin, V. P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.007 · Cited by 294
Pros and Cons of the Liposome Platform in Cancer Drug Targeting
Gabizon, A. A., Shmeeda, H., & Zalipsky, S. (2006) · Journal of Liposome Research · doi:10.1080/08982100600848769 · Cited by 272
Biocleavable Polyrotaxane−Plasmid DNA Polyplex for Enhanced Gene Delivery
Ooya, T., Choi, H. S., Yamashita, A., Yui, N., Sugaya, Y., Kano, A., Maruyama, A., Akita, H., Ito, R., Kogure, K., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja055868+ · Cited by 270
An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes
Liu, W., Sun, S., Cao, Z., Zhang, X., Yao, K., Lu, W. W., & Luk, K. D. K. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.038 · Cited by 259
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome
Yang, T., Choi, M.-K., Cui, F.-D., Kim, J. S., Chung, S.-J., Shim, C.-K., & Kim, D.-D. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.011 · Cited by 245
Kim, S. H., Jeong, J. H., Chun, K. W., & Park, T. G. (2005) · Langmuir · doi:10.1021/la0502084 · Cited by 242
Drug targeting and tumor heterogeneity
Bae, Y. H. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.074 · Cited by 233
Drug targeting with nano-sized carrier systems
Yokoyama, M. (2005) · Journal of Artificial Organs · doi:10.1007/s10047-005-0285-0 · Cited by 232
Hong, R. L., Huang, C. J., Tseng, Y., Pang, V. F., Chen, S.-T., Liu, J. J., & Chang, F. (1999) · PubMed · Cited by 227
Wang, Y., Yu, L., Han, L., Sha, X., & Fang, X. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.033 · Cited by 226
Breunig, M., Hozsa, C., Lungwitz, U., Watanabe, K., Umeda, I., Kato, H., & Goepferich, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.016 · Cited by 205
Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate
Esmaeili, F., Ghahremani, M. H., Ostad, S. N., Atyabi, F., Seyedabadi, M., Malekshahi, M. R., Amini, M., & Dinarvand, R. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802088630 · Cited by 203
PEGylation of Nanocarrier Drug Delivery Systems: State of the Art
Howard, M. D., Jay, M., Dziubla, T. D., & Lu, X. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.021 · Cited by 202
Chau, Y., Tan, F. E., & Langer, R. (2004) · Bioconjugate Chemistry · doi:10.1021/bc0499174 · Cited by 187
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery
Cheng, Y. (2008) · Frontiers in Bioscience · doi:10.2741/2774 · Cited by 184
Netti, P. A., Roberge, S., Boucher, Y., Baxter, L. T., & Jain, R. K. (1996) · Microvascular Research · doi:10.1006/mvre.1996.0041 · Cited by 183
Tumor targeting using liposomal antineoplastic drugs
Huwyler, J. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1253 · Cited by 182
A vacuolar type H(+)-ATPase regulates cytoplasmic pH in murine macrophages.
Swallow, C. J., Grinstein, S., & Rotstein, O. D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39163-x · Cited by 179
Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism
Montcourrier, P., Silver, I., Farnoud, R., Bird, I., & Rochefort, H. (1997) · Clinical & Experimental Metastasis · doi:10.1023/a:1018446104071 · Cited by 176
ElBayoumi, T. A., & Torchilin, V. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2392 · Cited by 170
Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans.
Guasch, A., Deen, W. M., & Myers, B. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116831 · Cited by 156
Wang, Y., Liu, X., Sun, T., Xiong, M., & Wang, J. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.021 · Cited by 144
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Gryparis, E. C., Hatziapostolou, M., Papadimitriou, Ε., & Avgoustakis, K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.017 · Cited by 139
A Biodegradable pH-sensitive Micelle System for Targeting Acidic Solid Tumors
Sethuraman, V. A., Lee, M. C., & Bae, Y. H. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9480-4 · Cited by 135
Antitumor efficacy of a novel polymer-peptide-drug conjugate in human tumor xenograft models
Chau, Y., Padera, R. F., Dang, N. M., & Langer, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21495 · Cited by 126
Polymeric Micellar Delivery Systems in Oncology
Matsumura, Y. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn116 · Cited by 124
Xiong, X.-B., Huang, Y., Lü, W.-L., Zhang, X., Zhang, H., Nagai, T., & Zhang, Q. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20397 · Cited by 124
Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells
Yang, T., Choi, M.-K., Fu-de, C., Lee, S. J., Chung, S., Shim, C., & Kim, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9425-y · Cited by 119
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies
Dagar, S., Krishnadas, A., Rubinstein, I., Blend, M. J., & Onyüksel, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00242-6 · Cited by 119
Cho, Y. W., Park, S. A., Han, T. H., Son, D. H., Park, J. S., Oh, S. J., Moon, D. H., Cho, K.-J., Ahn, C.-H., Byun, Y., et al. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.10.002 · Cited by 119
Ligand based dendritic systems for tumor targeting
Agarwal, A., Saraf, S., Asthana, A., Gupta, U. D., Gajbhiye, V., & Jain, N. K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.09.024 · Cited by 112
ElBayoumi, T. A., & Torchilin, V. P. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.113 · Cited by 106
PEGylated and MMP-2 Specifically DePEGylated Quantum Dots: Comparative Evaluation of Cellular Uptake
Mok, H., Bae, K. H., Ahn, C., & Park, T. G. (2008) · Langmuir · doi:10.1021/la803542v · Cited by 100
Chau, Y., Dang, N. M., Tan, F. E., & Langer, R. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20548 · Cited by 94
Optical Imaging of Matrix Metalloproteinase-7 Activity in Vivo Using a Proteolytic Nanobeacon
Scherer, R. L., VanSaun, M. N., McIntyre, J. O., & Matrisian, L. M. (2008) · Molecular Imaging · doi:10.2310/7290.2008.00010 · Cited by 93
Factors affecting toxicity and efficacy of polymeric nanomedicines
Igarashi, E. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.02.007 · Cited by 90
Stabilized Nanocarriers for Plasmids Based Upon Cross-linked Poly(ethylene imine)
Neu, M., Sitterberg, J., Bakowsky, U., & Kissel, T. (2006) · Biomacromolecules · doi:10.1021/bm060788z · Cited by 88
Lee, S., Park, K., Lee, S. Y., Ryu, J. H., Park, J. W., Ahn, H. J., Kwon, I. C., Youn, I., Kim, K., & Choi, K. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800264z · Cited by 85
Hu, Z., Luo, F., Pan, Y., Hou, C., Ren, L., Chen, J., Wang, J., & Zhang, Y. (2007) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31615 · Cited by 82
Disposition of Drugs in Block Copolymer Micelle Delivery Systems: From Discovery to Recovery
Aliabadi, H. M., Shahin, M., Brocks, D. R., & Lavasanifar, A. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847100-00001 · Cited by 78
Xiong, X.-B., Huang, Y., Lü, W.-L., Zhang, H., Zhang, X., & Zhang, Q. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-4588-x · Cited by 72
ElBayoumi, T. A., & Torchilin, V. P. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8001528 · Cited by 68
Herceptin-Geldanamycin Immunoconjugates
Mandler, R., Kobayashi, H., Hinson, E. R., Brechbiel, M. W., & Waldmann, T. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2485 · Cited by 60
Screening effect of PEG on avidin binding to liposome surface receptors
Kaasgaard, T., Mouritsen, O. G., & Jørgensen, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00633-5 · Cited by 45
Ozawa, M. G., Zurita, A. J., Dias‐Neto, E., Nunes, D. N., Sidman, R. L., Gelovani, J. G., Arap, W., & Pasqualini, R. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.03.001 · Cited by 45
Evaluation of Drug Targeting Strategies and Liposomal Trafficking
Oku, N., Tokudome, Y., Asai, T., & Tsukada, H. (2000) · Current Pharmaceutical Design · doi:10.2174/1381612003398816 · Cited by 40
Lu, Y. J., Xu, L., Parker, N. L., Westrick, E. M., Reddy, J. A., Vetzel, M., Low, P. S., & Leamon, C. P. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0439 · Cited by 35
Colbern, G. T., Hiller, A. J., Musterer, R., et al. (1999) · Journal of Liposome Research · doi:10.3109/08982109909035551 · Cited by 34
Cited by
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Mechanisms of drug release in nanotherapeutic delivery systems
Wong, P. T., & Choi, S. K. (2015) · Chemical Reviews · doi:10.1021/cr5004634 · Cited by 507
Receptor-targeted nanocarriers for therapeutic delivery to cancer
Yu, B., Tai, H. C., Xue, W., Lee, L. J., & Lee, R. J. (2010) · Molecular Membrane Biology · doi:10.3109/09687688.2010.521200 · Cited by 423
Bacteria‐Responsive Multifunctional Nanogel for Targeted Antibiotic Delivery
Xiong, M., Li, Y., Bao, Y., Yang, X., Hu, B., & Wang, J. (2012) · Advanced Materials · doi:10.1002/adma.201202847 · Cited by 299
Drug resistance in cancer: mechanisms and tackling strategies
Haider, T., Pandey, V., Banjare, N., Gupta, P. N., & Soni, V. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00138-7 · Cited by 282
Metadata
- Authors
- Gullotti, E., & Yeo, Y.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-05-01
- Volume
- 6
- Issue
- 4
- Pages
- 1041-1051
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1978267970
- Cited by
- 473
- References
- 109
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.